基本资料 投资组合 财务数据 基金公告
创金合信全球医药生物股票发起(QDII)C(018156) |
净值：
1.3652
|
日增长率：
3.16%
|
累计净值：1.3652 | 2026-11-09 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| PTGX | Protagonist Therapeutics Inc | 13,206.00 | 12,531,282.20 | 4.69 |
| CYTK | Cytokinetics Inc | 26,368.00 | 11,705,030.51 | 4.38 |
| EWTX | Edgewise Therapeutics Inc | 42,509.00 | 11,623,876.06 | 4.35 |
| COGT | Cogent Biosciences Inc | 53,489.00 | 11,535,325.52 | 4.31 |
| NKTR | 内克塔治疗 | 27,891.00 | 11,373,297.97 | 4.25 |
| KRYS | Krystal Biotech Inc | 5,040.00 | 11,288,717.27 | 4.22 |
| DFTX | Definium Therapeutics Inc | 44,000.00 | 11,278,867.86 | 4.22 |
| SYRE | Spyre Therapeutics Inc | 18,495.00 | 11,090,082.00 | 4.15 |
| ORIC | Oric Pharmaceuticals Inc | 120,800.00 | 10,959,193.08 | 4.10 |
| URGN | 乌龙制药 | 40,000.00 | 10,945,884.52 | 4.09 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-09-30 | 85.04 | 1.28 | 13.70 | 267,387,637.58 |
| 2026-06-30 | 76.73 | - | 12.07 | 291,295,201.59 |
| 2026-03-31 | 79.10 | - | 20.45 | 294,545,476.27 |
| 2025-12-31 | 89.93 | - | 20.40 | 825,065,395.56 |
| 2025-09-30 | 85.79 | - | 13.08 | 39,332,950.53 |
| 起始日 | 截止日 | 基金经理 | 任职天数 | 任期回报率% |
| 2026-08-05 | - | 皮劲松 | 99 | -15.44 |
| 2023-11-24 | 2026-09-24 | 毛丁丁 | 1035 | 50.51 |
| 2023-11-17 | 2026-02-10 | 皮劲松 | 816 | 65.44 |
微信公众号
证券之星APP
